nad+
Asset
Niacinamide is converted into NAD+ to support cellular energy production and DNA repair.
- Stage
- Phase 3
- Modality
- Supplement
- Target
- Sirtuin signalling
- 7
- Indications
- 5
- Trials
- 2
- Developers
Indications
7Aging
Phase 3, Active not recruiting, NCT07475546, clinicaltrials.gov, 7 Oct 2026
Healthspan improvement
Phase 3, Active not recruiting, NCT07475546, clinicaltrials.gov, 7 Oct 2026
Longevity
Phase 3, Active not recruiting, NCT07475546, clinicaltrials.gov, 7 Oct 2026
4 more
In the full profile
- Targets and what it contains2
- Owner and partners2
- Trials5
- Evidence for its targets3
- Competitors12
- Aging relevance2
- Signals14
Every asset’s record: target, stage, trials and the evidence behind it.